NCT06472804 Insomnia in Patients With Metastatic Lung Cancer
| NCT ID | NCT06472804 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Metastatic Lung Non-Small Cell Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2019-06-19 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2019-06-19 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
Eligibility Criteria
Inclusion Criteria: * Have a diagnosis of metastatic non small cell lung cancer * Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy * Older than 18 years old at the time of diagnosis Exclusion Criteria: * Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review
Contact & Investigator
Konstantinos Leventakos, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT06472804 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metastatic Lung Non-Small Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06472804 currently recruiting?
Yes, NCT06472804 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT06472804 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06472804 clinical trial?
NCT06472804 is sponsored by Mayo Clinic. The principal investigator is Konstantinos Leventakos, M.D., Ph.D. at Mayo Clinic in Rochester. The trial plans to enroll 60 participants.